Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Respirology Case Reports|December 22, 2025
Diagnostically Challenging Disseminated Bacillus Calmette-Guerin Infection With Lung and Liver Involvement: A Case ReportShinichi Chang, Makiko Yomota, Ayumi Takizawa, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|August 15, 2008
[Clinical statistics of outpatients investigated for asbestos-related lung diseases at a general hospital in Tokyo]Kazuyo Kaneko, Tatsuji Enomoto, Makiko Yomota, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2021
Cytokine Release Syndrome Induced by Immune-checkpoint Inhibitor Therapy for Non-small-cell Lung CancerMakiko Yomota, Kie Mirokuji, Masahiro Sakaguchi, et al.
Cancer Chemotherapy and Pharmacology|April 18, 2019
A single-arm phase II trial of weekly nanoparticle albumin-bound paclitaxel (nab-paclitaxel) monotherapy after standard of chemotherapy for previously treated advanced non-small cell lung cancerYasuhiro Kato, Yusuke Okuma, Kageaki Watanabe, et al.
Respiratory Care|December 13, 2012
Depression in Japanese patients with chronic obstructive pulmonary disease: a cross-sectional studyNobuyuki Horita, Takeshi Kaneko, Masaharu Shinkai, et al.
Plos One|April 5, 2013
Eligibility for bevacizumab as an independent prognostic factor for patients with advanced non-squamous non-small cell lung cancer: a retrospective cohort studyYusuke Takagi, Akira Toriihara, Yoshiro Nakahara, et al.
JTO Clinical and Research Reports|April 10, 2024
Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLCTsuyoshi Hirata, Yuji Uehara, Taiki Hakozaki, et al.
International Journal of Clinical Oncology|March 3, 2021
A case series on the safety of immunotherapy with reduced blood testing frequency in lung cancer patientsShoko Kawai, Kageaki Watanabe, Maiko Asai, et al.
Oncotargets and Therapy|March 24, 2025
Clinical Impact of Osimertinib Dose Reduction in the First-Line Setting on EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Retrospective Monocentric StudyHirokazu Iso, Makiko Yomota, Yukari Shirakura, et al.
JTO Clinical and Research Reports|January 6, 2025
Corrigendum to 'Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC' [JTO Clinical and Research Reports, Volume 5 Issue 4 (2024) 100659]Tsuyoshi Hirata, Yuji Uehara, Taiki Hakozaki, et al.
Pageof 5